Pioneers of mRNA win Nobel — plus our interview; Eli Lilly’s M&A, leadership shuffle; UniQure layoffs as gene therapy players adapt; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

Next week, John Car­roll and Drew Arm­strong will be host­ing a group of bio­phar­ma lead­ers in Lon­don for con­ver­sa­tions about the fu­ture of R&D in Eu­rope. Get your Eu­ro­Bio tick­ets now — and for those who are com­ing in per­son, I’ll be there with Rey­nald Cas­tañeda and the rest of the UK crew.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.